Giannis Mountzios, Director of the 4th Oncology Department and Clinical Trials Unit at Henry Dunant Hospital Center, shared a post on LinkedIn:
“Τhis weekend I had the unique opportunity to participate at the International Thoracic Cancer Debates ITCD 2026, an annual lung cancer consortium in Canary Islands, Spain, that brings together world-reknown lung cancer experts from around the globe for an intense 2-day brainstorming on new data and novel treatment options in the field of thoracic malignancies.
Together with my dear colleague and friend Helena Linardou we had the honor to represent Greece in a superb round table focusing on treatment advances in small-cell lung cancer SCLC. I had the opportunity to present novel data on fascinating new molecules such as T-cell engagers TCE, antibody-drug conjugates ADCs , radioligands and CAR-T cells among others. The therapeutic landscape in SCLC is evolving fast and I am so glad that we are able to provide more therapeutic options to our patients with lung cancer”
More posts featuring Giannis Mountzios
